Dhondt, Elisabeth http://orcid.org/0000-0001-6213-2031
Vanlangenhove, Peter
Geboes, Karen
Vandenabeele, Lisbeth
Van Cauwenberghe, Lien
Defreyne, Luc
Article History
Received: 28 March 2019
Revised: 30 June 2019
Accepted: 15 July 2019
First Online: 5 August 2019
Change Date: 6 July 2020
Change Type: Correction
Change Details: On request from the Editors, the authors would like to clarify the following: the patient cohorts in the publications ���No evidence of improved efficacy of covered stents over uncovered stents in percutaneous palliation of malignant hilar biliary obstruction: results of a prospective randomized trial���.
Compliance with ethical standards
:
: The scientific guarantor of this publication is Prof. Dr. Luc Defreyne.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in Vandenabeele, L.A.M., Dhondt, E., Geboes, K.P. and Defreyne, L. (2017) Percutaneous Stenting in Malignant Biliary Obstruction Caused By Metastatic Disease: Clinical Outcome and Prediction of Survival According to Tumor Type and Further Therapeutic Options. Acta Gastroenterol Belg 80(2): 249–55.
: • prospective• randomized controlled trial• performed at one institution